Up $1.60 or so in a couple of weeks. Coincidence since the down ramping stopped?
Printable View
..........
What down ramping?
I only noticed some posters pointing out quite real risks and quite significant management problems related to this investment.
What is wrong with that?
I guess we all will find out over time whether the risks eventuate or not - this is the nature of risks.
I don't consider pointing out risks as down ramping, quite the contrary. If you've read my thread which got almost no traction at all, perhaps because people don't like talking about risk (what could possibly go wrong, what is the likelihood and what is the consequence), I advocated good risk analysis and management and almost shared a methodology for that but no one seemed interested at the time.
Besides, the SML situation would not be managed as a risk per se, the risk of litigation over the covenants has emerged and it would now be managed by the business as an Issue. The approach would shift towards scenario impacts and their severity.
Down ramping imho is about repetitive ad nauseum negative statements typically laced with hyperbole intended, or with potential, to create uncertainty or a sense of risk that exceeds or plays up a worst case scenario rather than the actual circumstance or acknowledging or even considering the injured parties remedies (as opposed in this case to the liable party), possibly for or as openly stated for selfish reasons to acquire a share at a lower price.
GS.........IMF volumes for May-19 continue to be supportive for A2M $16.50 and SML $11.60 both stocks are Buy-Rated
SML now producing infant formula from its manufacturing factory in Auckland ...............